Advertisement

Topics

CARA Therapeutics Company Profile

12:17 EDT 23rd June 2018 | BioPortfolio

Cara possesses both near-term clinical development opportunities, combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's first patented compound, CR665, has entered clinical testing for acute pain. This best-in-class compound possesses unique analgesic and anti-inflammatory activities appropriate for multiple therapeutic applications. In addition, Cara aims to develop a future pipeline of first-in-class molecules at novel analgesic and anti-inflammatory targets using its proprietary drug screening technology.

Location

765 Old Saw Mill River Road
Tarrytown
New York
10591
United States of America

Contact

Phone: 914 347-4040
Fax: 914 347-4442
Email: info@caratherapeutics.com


News Articles [841 Associated News Articles listed on BioPortfolio]

CARA Stock Forecast: Why Cara Therapeutics Stock Soared 43%

Why CARA Stock Spiked Investors got a big surprise earlier this month when Cara Therapeutics Inc (NASDAQ:CARA) announced a new distribution channel for the "Korsuva" drug, which is currently pendin...

Vifor acquires rights to Cara's kidney disease drug

Cara Therapeutics gave Vifor Fresenius Medical Care Renal Pharma the rights to market Cara's Korsuva, or CR845/difelikefalin, -More- 

Cara Therapeutics' (CARA) CEO Derek Chalmers on Q1 2018 Results - Earnings Call Transcript

Cara Therapeutics' (CARA) CEO Derek Chalmers on Q4 2017 Results - Earnings Call Transcript

Cara Therapeutics Grabs $70 Million Upfront in Licensing Deal for Late-Stage Kidney Disease Drug

Shares of Cara Therapeutics are soaring this morning after the company announced it secured $70 million in cash as part of a licensing agreement with Vifor Fresenius Medical Care Renal Pharma Ltd. (VF...

Late-stage hemodialysis trial of Korsuva injection launched by Cara

Cara Therapeutics launched a Phase III trial that will evaluate the efficacy and safety of Korsuva, or CR845/difelikefalin, i -More- 

CARA Abuzz, CERS Up 20% In 5 Days, KURA Turns Heads, JNCE Making Iconic Moves

Cara Therapeutics Inc. gained 17.20% to close Wednesday's trading at $16.08. The Company's lead drug candidate is I.V. CR845, which is under a phase III safety study for the treatment of chronic kidne...

Cara out-licenses Korsuva injection ex-US rights to Vifor Fresenius for $520m

Cara Therapeutics has granted licensing worldwide rights with the exception of the US, Japan and South Korea to commercialize its Korsuva (CR845/difelikefalin) injection to Vifor Fresenius Medical Car...

PubMed Articles [435 Associated PubMed Articles listed on BioPortfolio]

PS-CARA: Context-Aware Resource Allocation Scheme for Mobile Public Safety Networks.

The fifth-generation (5G) communications systems are expecting to support users with diverse quality-of-service (QoS) requirements. Beside these requirements, the task with utmost importance is to sup...

RNA Therapeutics (Almost) Comes of Age: Targeting, Delivery and Endosomal Escape.

Protective effect of bioaccessible fractions of citrus fruit pulps against H2O2-induced oxidative stress in Caco-2 cells.

Fruit pulps from Navel (N) and Cara Cara (CC) oranges, and Clementine mandarin freshly harvested (M) and refrigerated stored (M12) were used to evaluate the cytoprotective effect of their bioaccessibl...

Recent developments in intracellular protein delivery.

Protein therapeutics based on transcription factors, gene editing enzymes, signaling proteins and protein antigens, have the potential to provide cures for a wide number of untreatable diseases, but c...

Alternative therapeutics for self-limiting infections-An indirect approach to the antibiotic resistance challenge.

Alternative therapeutics for infectious diseases is a top priority, but what infections should be the primary targets? At present there is a focus on therapies for severe infections, for which effecti...

Clinical Trials [146 Associated Clinical Trials listed on BioPortfolio]

Metabolomic Approach to Evaluate the Effect of Orange Juice Intake in Healthy Humans (METABORANGE).

This study evaluates the effect of intake of two orange juice varieties in healthy adults. The participants will receive "Bahia" orange juice, "Cara-Cara" orange juice or a isocaloric cont...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

Companies [1238 Associated Companies listed on BioPortfolio]

CARA Therapeutics

Cara possesses both near-term clinical development opportunities, combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's first patented compound, CR665, has enter...

Cara Therapeutics, Inc.

CARA THERAPEUTICS -- OU NAME

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

More Information about "CARA Therapeutics" on BioPortfolio

We have published hundreds of CARA Therapeutics news stories on BioPortfolio along with dozens of CARA Therapeutics Clinical Trials and PubMed Articles about CARA Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CARA Therapeutics Companies in our database. You can also find out about relevant CARA Therapeutics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Anesthesiology
An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...

Pain
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record